Hexin Yan

8PUBLICATIONS
31CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Computational chemistryMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 10, 2025
Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Kang He, Xue-Jing Zhu, Yao-Ping Shi

|Nov 05, 2025
Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Kang He, Xue-Jing Zhu, Yao-Ping Shi

|Feb 28, 2025
Inhibition of liver cancer cell growth by metabolites S-adenosylmethionine and nicotinic acid originating from liver progenitor cells.

Wen-Ming Liu, Cai-Yang Chen, Hong-Qian Ma

|Jan 22, 2025
Triple knockdown of CD11a, CD49d, and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice.

Hongye Wang, Zhaorong Wu, Dan Cui

|Oct 02, 2023
CD24+LCN2+ liver progenitor cells in ductular reaction contributed to macrophage inflammatory responses in chronic liver injury.

Wei-Jian Huang, Bi-Jun Qiu, Xiao-Shu Qi

|Aug 23, 2022
EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma.

Xuhui Ma, Shanshan Wu, Botai Li

Pageof 2

Frequent Collaborators

3 joint publications

Wei-Feng Yu

2 joint publications

Bo Zhai

2 joint publications

Kang He

2 joint publications

Pei-Ying Li